Law360 (March 13, 2008, 12:00 AM EDT) -- Germany's drug safety regulator ordered companies in the country on Wednesday to test their stocks of heparin, a blood thinner at the center of an international recall, for any signs of contamination.
Last week, Rotexmedica GmbH, a unit of Groupe Panpharma, recalled three batches of heparin in Germany after 80 dialysis patients who took the drug experienced allergic reactions to it.
On Wednesday, the Federal Institute for Drugs and Medical Devices asked 10 heparin manufacturers to carry out additional tests and hopes to get results soon. Ulrich Hagemann, who oversees pharmaceutical safety for the agency, called the directive a “precautionary measure.”...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!